Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer.

MLA

Lee, W.Robert, et al. “Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 42, no. 20, July 2024, pp. 2377–81. EBSCOhost, https://doi.org/10.1200/JCO.23.02445.

APA

Lee, W. R., Dignam, J. J., Amin, M. B., Bruner, D. W., Low, D., Swanson, G. P., Shah, A. B., D’Souza, D., Michalski, J. M., Dayes, I. S., Seaward, S. A., Hall, W. A., Nguyen, P. L., Pisansky, T. M., Faria, S. L., Chen, Y., Rodgers, J. P., & Sandler, H. M. (2024). Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 42(20), 2377–2381. https://doi.org/10.1200/JCO.23.02445

Chicago

Lee, W Robert, James J Dignam, Mahul B Amin, Deborah W Bruner, Daniel Low, Gregory P Swanson, Amit B Shah, et al. 2024. “Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 42 (20): 2377–81. doi:10.1200/JCO.23.02445.